Big Rock Partners Acquisition Corp.

Status: Closed Deal

U=S+R+W/2 W=S@11.5 R=S/10

IPO Proceeds, $M	$69.00M
IPO Date	Nov 20, 2017
CEO	Richard Ackerman
Left Lead	EarlyBirdCapital
IPO Cash in Trust	100.0%
SPAC Tenor	12+3+3+3+3+4+4+5+4+1
IPO Sector	Healthcare Senior housing and care industry in the United States
IPO Geography	US/Canada
Target Company	NeuroRx
Deal Announced	Dec 14, 2020
Deal Size, $M	$525.07M
Deal Sector	Healthcare
Deal Geography	US/Canada
SEC Filings	www.sec.gov
Approval Vote	May 24, 2021
Amendment Vote	TBD
Closing Date	May 24, 2021

Formerly BRPA NRXP NRXPW

Price	$3.23 $0.32
Last closing price	$3.55
H/L, today	$3.19 / $3.65
H/L, 52-week	$0.22 / $1.53
Volume, today	649,155
Volume, 3-month avg.	N/A

Price
Volume, today
Volume, 3-month avg.	N/A

Price	$0.18
Last closing price	$0.17
High/low price, today	$0.18 / $0.18
High/low price, 52-week	$0.05 / $0.44
Volume, today	2,346
Volume, 3-month avg.	N/A

Price
Volume, today
Volume, 3-month avg.	N/A

No credit card required

Structure and cap table
6 directors & officers
50 filings and events
2 underwriters
3 legal advisors

Structure

Sign in to view structure, cap table, and calendar of events.

Team

Name	Age	Title
Richard Ackerman	59	Chairman, President and Chief Executive Officer
Bennett Kim	58	Chief Financial Officer
Michael Fong	73	Director
Albert G. Rex	62	Director
Troy T. Taylor	59	Director
Richard J. Birdoff	58	Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors

Underwriters
EarlyBirdCapital	BR	5,400,000	units
I-Bankers Securities		600,000
		6,000,000	units
	Up-Front UW fee	2.50	%
BCMA		4.00	%

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings


Nov 20, 2017	IPO Prospectus
Nov 22, 2017	8-K announcing pricing of IPO Sign In to view filing content.
Nov 29, 2017	8-K announcing separate trading of common stock, rights and warrants Sign In to view filing content.
Nov 19, 2018	Press Release announcing extension of liquidation deadline Sign In to view filing content.
Nov 20, 2018	8-K detailing Agreement with BRAC Lending Group in connection with charter extension Sign In to view filing content.
Jan 16, 2019	8-K with notice of failure to satisfy a continued listing rule Sign In to view filing content.
Feb 22, 2019	8-K announcing extension of time to consummate business combination Sign In to view filing content.
Apr 26, 2019	PRE14A Preliminary Proxy for shareholder meeting to extend charter Sign In to view filing content.
May 7, 2019	DEF14A Definitive Proxy for shareholder meeting to extend charter Sign In to view filing content.
May 22, 2019	8-K with extension meeting results Sign In to view filing content.
Jun 20, 2019	8-K announcing contribution to trust Sign In to view filing content.
Jul 18, 2019	8-K announcing contribution to trust account Sign In to view filing content.
Jul 30, 2019	PRE14A Preliminary proxy for shareholder meeting to extend charter Sign In to view filing content.
Aug 9, 2019	DEF14A Definitive Proxy for shareholder meeting to extend charter Sign In to view filing content.
Aug 12, 2019	8-K with notice of delisting or failure to satisfy a continued listing rule Sign In to view filing content.
Aug 23, 2019	8-K announcing approval of charter extension Sign In to view filing content.
Oct 29, 2019	PRE14A Preliminary proxy for charter extension meeting Sign In to view filing content.
Nov 8, 2019	DEF14A Definitive Proxy for extension meeting Sign In to view filing content.
Nov 22, 2019	8-K announcing results of extension meeting Sign In to view filing content.
Feb 11, 2020	8-K announcing change in directors Sign In to view filing content.
Feb 27, 2020	PRE14A Preliminary proxy for shareholder meeting to extend charter Sign In to view filing content.
Mar 9, 2020	DEF14A Definitive proxy for shareholder meeting to extend charter Sign In to view filing content.
Mar 24, 2020	8-K announcing approval of charter extension Sign In to view filing content.
Jun 29, 2020	PRE14A Preliminary proxy for shareholder meeting to extend charter Sign In to view filing content.
Jul 10, 2020	DEF14A Definitive proxy for shareholder meeting to extend charter Sign In to view filing content.
Jul 24, 2020	8-K with extension meeting results Sign In to view filing content.
Nov 25, 2020	PRE14A Preliminary proxy for charter extension meeting Sign In to view filing content.
Dec 7, 2020	PRER14A Revised preliminary proxy for charter extension meeting Sign In to view filing content.
Dec 7, 2020	DEF14A Definitive proxy for shareholder meeting to extend charter Sign In to view filing content.
Dec 14, 2020	PR announcing business combination with NeuroRx, Inc. Sign In to view filing content.
Dec 17, 2020	8-K with full NeuroRx Merger Agreement Sign In to view filing content.
Dec 18, 2020	8-K with extension meeting results Sign In to view filing content.
Jan 27, 2021	S-4 registration statement containing preliminary proxy for NeuroRx business combination Sign In to view filing content.
Feb 9, 2021	8-Ks with updates on intended merger target - NeuroRx Sign In to view filing content.
Mar 15, 2021	8-K announcing $10mm PIPE commitment Sign In to view filing content.
Mar 22, 2021	8-K/A Amendment #2 to business combination agreement Sign In to view filing content.
Mar 22, 2021	PRE14A Preliminary proxy for charter extension meeting Sign In to view filing content.
Apr 1, 2021	DEF14A Definitive proxy for charter extension meeting Sign In to view filing content.
Apr 16, 2021	S-4/A Amendment #1 to registration statement containing preliminary proxy for NeuroRx business combination Sign In to view filing content.
Apr 21, 2021	8-K with extension meeting results Sign In to view filing content.
May 12, 2021	S-4/A Amendment #2 to registration statement containing preliminary proxy for NeuroRx business combination Sign In to view filing content.
May 19, 2021	S-4/A Amendment #3 to registration statement containing preliminary proxy for NeuroRx business combination Sign In to view filing content.
May 20, 2021	S-4/A Amendment #4 to registration statement containing preliminary proxy for NeuroRx business combination Sign In to view filing content.
May 21, 2021	424B3 Definitive proxy/prospectus for NeuroRx business transaction Sign In to view filing content.
May 24, 2021	CA Corporate Action Alert announcing closing of NeuroRx business combination Sign In to view filing content.
May 26, 2021	8-K with closing details Sign In to view filing content.
May 28, 2021	Super 8-K for closing of NeuroRx business combination Sign In to view filing content.
Jun 25, 2021	S-1 Post-closing registration statement Sign In to view filing content.
Jul 6, 2021	S-1/A Amendment to post-closing registration statement Sign In to view filing content.
Jul 9, 2021	EFFECT Effectiveness of post-closing registration statement Sign In to view filing content.